Recent Quotes (30 days)

You have no recent quotes
chg | %

Elite Pharmaceuticals Inc  

(Public, OTCBB:ELTP)   Watch this stock  
Find more results for elite
0.345
+0.003 (0.82%)
Apr 17 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.33 - 0.36
52 week 0.06 - 0.97
Open 0.36
Vol / Avg. 405,416.00/5.93M
Mkt cap 193.14M
P/E     -
Div/yield     -
EPS -0.02
Shares 560.14M
Beta -0.14
Inst. own 0%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -62.71% 43.72%
Operating margin -73.06% -45.93%
EBITD margin - -33.49%
Return on average assets -23.87% 13.88%
Return on average equity - -
Employees 26 -
CDP Score - -

Address

165 Ludlow Avenue
NORTHVALE, NJ 07647
United States - Map
+1-201-7502646 (Phone)
+1-201-7502755 (Fax)

Website links

Description

Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products). The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�s propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�s Abuse Resistant Technology).

Officers and directors

Jerry I. Treppel Chairman of the Board
Age: 59
Nasrat Hakim President, Chief Executive Officer, Director
Age: 52
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 49
Ashok G. Nigalaye Ph.D. Chief Scientific Officer, Director
Age: 61
Jeenarine Narine Director
Age: 62
Barry H. Dash Ph.D. Independent Director
Age: 81
Jeffrey A. Whitnell Independent Director
Age: 57